The science of dermocosmetics and its role in dermatology

Journal of the European Academy of Dermatology and Venereology

Volumn 28, Issue 11, 2014, Pages 1409-1417

  Dreno, B ^a   Araviiskaia, E ^b   Berardesca, E ^c   Bieber, T ^d   Hawk, J ^e   Sanchez Viera, M ^f   Wolkenstein, P ^g  

^a UNIVERSITÉ DE NANTES   (France)

^b PAVLOV FIRST SAINT PETERSBURG STATE MEDICAL UNIVERSITY   (Russian Federation)

^c SAN GALLICANO DERMATOLOGICAL INSTITUTE   (Italy)

^d UNIVERSITY OF BONN   (Germany)

^e ST THOMAS HOSPITAL   (United Kingdom)

^f Institute for Dermatology   (Spain)

^g HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COSMETIC;

COSMETIC INDUSTRY; DERMATOLOGY; DERMATOLOGY LIFE QUALITY INDEX; DISEASE SURVEILLANCE; FUNCTIONS OF THE SKIN AND ITS APPENDAGES; HUMAN; IN VITRO STUDY; PERSONAL APPEARANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SKIN SURGERY;

EID: 85007158186     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/jdv.12497     Document Type: Review

References (102)

1. Brandt FS, Cazzaniga A, Hann M. Cosmeceuticals: current trends and market analysis. Semin Cutan Med Surg 2011; 30: 141–143.
2. Newburger AE. Cosmeceuticals: myths and misconceptions. Clin Dermatol 2009; 27: 446–452.
3. Proxim. What is the dermocosmetic approach? [WWW document] URL http://www.groupeproxim.ca/en/beauty/dermocosmetics/definition.sn (last accessed: 15 October 2013).
4. Kimball AB, Grant RA, Wang F, Osborne R, Tiesman JP. Beyond the blot: cutting edge tools for genomics, proteomics and metabolomics analyses and previous successes. Br J Dermatol 2012; 166(Suppl 2): 1–8.
5. Draelos ZD. Cosmeceuticals: undefined, unclassified, and unregulated. Clin Dermatol 2009; 27: 431–434.
6. Zuang V, Rona C, Archer G, Berardesca E. Detection of skin irritation potential of cosmetics by non-invasive measurements. Skin Pharmacol Appl Skin Physiol 2000; 13: 358–371.
7. ISO. European Standardisation Organisation: EN ISO 24444:2010. Cosmetics, Sun protection test methods – In vivo Determination of Sun Protection Factor (SPF). [WWW document] 2010. URL http://www.iso.org/iso/catalogue_detail.htm?csnumber=46523 (last accessed: 14 January 2014)
8. Rheinwald JG, Green H. Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell 1975; 6: 331–343.
9. Bell E, Ivarsson B, Merrill C. Production of a tissue-like structure by contraction of collagen lattices by human fibroblasts of different proliferative potential in vitro. Proc Natl Acad Sci USA 1979; 76: 1274–1278.
10. Semlin L, Schafer-Korting M, Borelli C, Korting HC. In vitro models for human skin disease. Drug Discov Today 2011; 16: 132–139.
11. Cosmetics Europe. Guidelines on the Product Information File (PIF) requirement. [WWW document] 2011. URL https://www.cosmeticseurope.eu/publications-cosmetics-europe-association/guidelines.html?view=item&id=85 (last accessed: 14 January 2014)
12. Duval C, Schmidt R, Regnier M, Facy V, Asselineau D, Bernerd F. The use of reconstructed human skin to evaluate UV-induced modifications and sunscreen efficacy. Exp Dermatol 2003; 12(Suppl 2): 64–70.
13. Braye F, Hautier A, Bouez C, Damour O. Skin substitutes reconstructed in the laboratory: application in burn treatment. Pathol Biol (Paris) 2005; 53: 613–617.
14. Ehrlich HP. Understanding experimental biology of skin equivalent: from laboratory to clinical use in patients with burns and chronic wounds. Am J Surg 2004; 187: 29S–33S.
15. OECD. Guideline for the testing of chemicals, draft proposal for a new guideline: in vitro skin irritation: human skin model test. [WWW document] 2008. URL http://www.google.co.uk/url?sa=t&rct=j&q=&esrc=s&frm=1&source=web&cd=1&ved=0CDAQFjAA&url=http%3A%2F%2Fwww.oecd.org%2Fdataoecd%2F21%2F56%2F40793105.doc&ei=LvXTUpiHKceBhAf9lIDoDg&usg=AFQjCNGl7qZLcTlSKbXBk6u5mjiIzHJUPw&sig2=hMa5LXBQFlcEe5PfY4B_0A (last accessed: 19 March 2014)
16. Michelet JF, Olive C, Rieux E et al. The anti-ageing potential of a new jasmonic acid derivative (LR2412): in vitro evaluation using reconstructed epidermis Episkin. Exp Dermatol 2012; 21: 398–400.
17. Tosato MG, Alves RS, Dos Santos EA et al. Raman spectroscopic investigation of the effects of cosmetic formulations on the constituents and properties of human skin. Photomed Laser Surg 2012; 30: 85–91.
18. Deloche C, Minondo AM, Bernard BA et al. Effect of C-xyloside on morphogenesis of the dermal epidermal junction in aged female skin. An ultrastuctural pilot study. Eur J Dermatol 2011; 21: 191–196.
19. El Madani HA, Tancrede-Bohin E, Bensussan A et al. In vivo multiphoton imaging of human skin: assessment of topical corticosteroid-induced epidermis atrophy and depigmentation. J Biomed Opt 2012; 17: 026009.
20. de Rigal J, Escoffier C, Querleux B, Faivre B, Agache P, Leveque JL. Assessment of aging of the human skin by in vivo ultrasonic imaging. J Invest Dermatol 1989; 93: 621–625.
21. Abbott S. An integrated approach to optimizing skin delivery of cosmetic and pharmaceutical actives. Int J Cosmet Sci 2012; 34: 217–222.
22. Cosmetics Europe. Guidelines on stability testing of cosmetic products. [WWW document] 2004. URL https://www.cosmeticseurope.eu/publications-cosmetics-europe-association/guidelines.html?view=item&id=20 (last accessed: 31 January 2013).
23. Otto A, du Plessis J, Wiechers JW. Formulation effects of topical emulsions on transdermal and dermal delivery. Int J Cosmet Sci 2009; 31: 1–19.
24. Cosmetics Europe. Guidelines for percutaneous absorption/penetration. [WWW document] 1997. URL https://www.cosmeticseurope.eu/publications-cosmetics-europe-association/guidelines.html?view=item&id=26 (last accessed: 15 October 2013).
25. Lane ME, Hadgraft J, Oliveira G, Vieira R, Mohammed D, Hirata K. Rational formulation design. Int J Cosmet Sci 2012; 34: 496–501.
26. Kulkamp-Guerreiro IC, Berlitz SJ, Contri RV et al. Influence of nanoencapsulation on the sensory properties of cosmetic formulations containing lipoic acid. Int J Cosmet Sci 2013; 35: 105–111.
27. Devaux S, Castela A, Archier E et al. Adherence to topical treatment in psoriasis: a systematic literature review. J Eur Acad Dermatol Venereol 2012; 26 (Suppl 3): 61–67.
28. Dreno B, Thiboutot D, Gollnick H et al. Large-scale worldwide observational study of adherence with acne therapy. Int J Dermatol 2010; 49: 448–456.
29. Cosmetics Directive. Post-Market Surveillance[WWW document]. URL https://www.cosmeticseurope.eu/safety-and-science-cosmetics-europe/safety-in-cosmetics/post-market-surveillance-.html (last accessed: 15 October 2013).
30. Escalas-Taberner J, Gonzalez-Guerra E. Guerra-Tapia A [Sensitive skin: a complex syndrome]. Actas Dermosifiliogr 2011; 102: 563–571.
31. Gerberick GF, Robinson MK, Felter SP, White IR, Basketter DA. Understanding fragrance allergy using an exposure-based risk assessment approach. Contact Derm 2001; 45: 333–340.
32. Scientific Committee on Consumer Safety (SCCS). Opinion of the Scientific Committee on Cosmetic Products and Non-Food Products Intended for Consumers. SCCNFP/0392/00. [WWW document] 2001. URL http://ec.europa.eu/health/ph_risk/committees/04_sccp/docs/sccp_o_036.pdf (last accessed: 14 January 2014)
33. Aeby P, Ashikaga T, Bessou-Touya S et al. Identifying and characterizing chemical skin sensitizers without animal testing: Colipa's research and method development program. Toxicol In Vitro 2010; 24: 1465–1473.
34. REACH Programme: Registration, Evaluation, Authorisation and Restriction of Chemical substances. [WWW document] 2007. URL http://ec.europa.eu/enterprise/sectors/chemicals/reach/index_en.htm (last accessed: 15 October 2013).
35. Cosmetics Europe. Colipa Guidelines on the Management and reporting of Undesirable Event Reports in the context of EU Cosmetovigilance. [WWW document] 2008. URL http://www.likochema.lt/docs/naujienos/COSVIG_Guidelines_updated.pdf (last accessed: 14 January 2014)
36. Bazin R and Flament F. In Med'Com (Editions) Skin Aging Atlas, Vol 2, Asian Type, Paris, France, 2010: 32–95.
37. Musnier C, Piquemal P, Beau P, Pittet JC. Visual evaluation in vivo of ‘complexion radiance’ using the C.L.B.T.™ sensory methodology. Skin Res Technol 2004; 10: 50–56.
38. Oi N, Ohi K. The psychosocial influence to habit using make-up of women aged 40 to 59 years menopausal Japanese women. Int J Cosmet Sci 2013; 35: 64–68.
39. Beresniak A, de Linares Y, Krueger GG et al. Validation of a new international quality-of-life instrument specific to cosmetics and physical appearance: beautyQoL questionnaire. Arch Dermatol 2012; 148: 1275–1282.
40. Matsuoka Y, Yoneda K, Sadahira C, Katsuura J, Moriue T, Kubota Y. Effects of skin care and makeup under instructions from dermatologists on the quality of life of female patients with acne vulgaris. J Dermatol 2006; 33: 745–752.
41. Segot-Chicq E, Compan-Zaouati D, Wolkenstein P et al. Development and validation of a questionnaire to evaluate how a cosmetic product for oily skin is able to improve well-being in women. J Eur Acad Dermatol Venereol 2007; 21: 1181–1186.
42. Fu JJ, Hillebrand GG, Raleigh P et al. A randomized, controlled comparative study of the wrinkle reduction benefits of a cosmetic niacinamide/peptide/retinyl propionate product regimen vs. a prescription 0.02% tretinoin product regimen. Br J Dermatol 2010; 162: 647–654.
43. CONSORT. Welcome to the CONSORT Statement Website. [WWW document] 2010. URL http://www.consort-statement.org/ (last accessed: 15 October 2013).
44. ICH. International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. Guideline for good clinical practice E6(R1). [WWW document] 1996. URL http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E6_R1/Step4/E6_R1__Guideline.pdf. (last accessed: 14 January 2014)
45. Watson RE, Ogden S, Cotterell LF et al. Effects of a cosmetic ‘anti-ageing’ product improves photoaged skin [corrected]. Br J Dermatol 2009; 161: 419–426.
46. Gerlach N, Graf R, Witte G et al. Sebusuppressive efficacy of the antioxidant bis-ethylhexyl hydroxydimethoxy benzylmalonate in the treatment of oily and blemished skin. Clin Cosmet Investig Dermatol 2012; 5: 101–109.
47. Brennan M, Young G, Devane D. Topical preparations for preventing stretch marks in pregnancy. Cochrane Database Syst Rev 2012;11:CD000066.
48. Cosmetics Europe. Responsible Advertising [WWW document]. URL https://www.cosmeticseurope.eu/responsible-industry-the-european-cosmetic-cosmetics-association/responsible-advertising.html (last accessed: 15 October 2013).
49. European Commission. Cosmetic products. [WWW document] 2009. URL http://ec.europa.eu/enterprise/policies/european-standards/harmonised-standards/cosmetic-products/index_en.htm (last accessed: 15 October 2013).
50. European Commission, Consumers. [WWW document] 2013. URL http://ec.europa.eu/consumers/sectors/cosmetics/marketsurveillance/index_en.htm (last accessed: 15 October 2013).
51. Fitz-Gibbon S, Tomida S, Chiu BH et al. Propionibacterium acnes strain populations in the human skin microbiome associated with acne. J Invest Dermatol 2013; 133: 2152–2160.
52. Ramos-e-Silva M, Jacques C. Epidermal barrier function and systemic diseases. Clin Dermatol 2012; 30: 277–279.
53. Wolf R, Orion E, Ruocco E, Ruocco V. Abnormal epidermal barrier in the pathogenesis of psoriasis. Clin Dermatol 2012; 30: 323–328.
54. Gelmetti C. Therapeutic moisturizers as adjuvant therapy for psoriasis patients. Am J Clin Dermatol 2009; 10(Suppl 1): 7–12.
55. Kottner J, Lichterfeld A, Blume-Peytavi U. Maintaining skin integrity in the aged: a systematic review. Br J Dermatol 2013; 169: 528–542.
56. Wiren K, Nohlgard C, Nyberg F et al. Treatment with a barrier-strengthening moisturizing cream delays relapse of atopic dermatitis: a prospective and randomized controlled clinical trial. J Eur Acad Dermatol Venereol 2009; 23: 1267–1272.
57. Fluhr JW, Miteva M, Primavera G, Ziemer M, Elsner P, Berardesca E. Functional assessment of a skin care system in patients on chemotherapy. Skin Pharmacol Physiol 2007; 20: 253–259.
58. Halperin EC, Gaspar L, George S, Darr D, Pinnell S. A double-blind, randomized, prospective trial to evaluate topical vitamin C solution for the prevention of radiation dermatitis. CNS Cancer Consortium. Int J Radiat Oncol Biol Phys 1993; 26: 413–416.
59. Lacouture ME, Mitchell EP, Piperdi B et al. Skin toxicity evaluation protocol with panitumumab (STEPP), a phase II, open-label, randomized trial evaluating the impact of a pre-Emptive Skin treatment regimen on skin toxicities and quality of life in patients with metastatic colorectal cancer. J Clin Oncol 2010; 28: 1351–1357.
60. Pardo Masferrer J, Murcia Mejia M, Vidal Fernandez M et al. Prophylaxis with a cream containing urea reduces the incidence and severity of radio-induced dermatitis. Clin Transl Oncol 2010;12:43–48.
61. Schmuth M, Wimmer MA, Hofer S et al. Topical corticosteroid therapy for acute radiation dermatitis: a prospective, randomized, double-blind study. Br J Dermatol 2002; 146: 983–991.
62. Dreno B, Bensadoun RJ, Humbert P et al. Algorithm for dermocosmetic use in the management of cutaneous side-effects associated with targeted therapy in oncology. J Eur Acad Dermatol Venereol 2013; 27: 1071–1080.
63. Wild CP. The exposome: from concept to utility. Int J Epidemiol 2012; 41: 24–32.
64. Dancik Y, Favre A, Loy CJ, Zvyagin AV, Roberts MS. Use of multiphoton tomography and fluorescence lifetime imaging to investigate skin pigmentation in vivo. J Biomed Opt 2013; 18: 26022.
65. Li X, Galzote C, Yan X, Li L, Wang X. Characterization of Chinese body skin through in vivo instrument assessments, visual evaluations, and questionnaire: influences of body area, inter-generation, season, sex, and skin care habits. Skin Res Technol 2014; 20: 14–22.
66. Qiu H, Flament F, Long X et al. Seasonal skin darkening in Chinese women: the Shanghaiese experience of daily sun protection. Clin Cosmet Investig Dermatol 2013; 6: 151–158.
67. Klang V, Schwarz JC, Haberfeld S, Xiao P, Wirth M, Valenta C. Skin integrity testing and monitoring of in vitro tape stripping by capacitance-based sensor imaging. Skin Res Technol 2013; 19: e259–272.
68. Luebberding S, Krueger N, Kerscher M. Skin physiology in men and women: in vivo evaluation of 300 people including TEWL, SC hydration, sebum content and skin surface pH. Int J Cosmet Sci 2013; 35: 477–483.
69. Baspeyras M, Rouvrais C, Liegard L et al. Clinical and biometrological efficacy of a hyaluronic acid-based mesotherapy product: a randomised controlled study. Arch Dermatol Res 2013; 305: 673–682.
70. Danczak-Pazdrowska A, Polanska A, Silny W et al. Seemingly healthy skin in atopic dermatitis: observations with the use of high-frequency ultrasonography, preliminary study. Skin Res Technol 2012; 18: 162–167.
71. Hutton Carlsen K, Tolstrup J, Serup J. High-frequency ultrasound imaging of tattoo reactions with histopathology as a comparative method. Introduction of preoperative ultrasound diagnostics as a guide to therapeutic intervention. Skin Res Technol 2013; DOI: 10.1111/srt.12110. [Epub ahead of print].
72. Choi JW, Kwon SH, Huh CH, Park KC, Youn SW. The influences of skin visco-elasticity, hydration level and aging on the formation of wrinkles: a comprehensive and objective approach. Skin Res Technol 2013; 19: e349–355.
73. Kim BY, Choi JW, Park KC, Youn SW. Sebum, acne, skin elasticity, and gender difference - which is the major influencing factor for facial pores? Skin Res Technol 2013; 19: e45–53.
74. Pierard GE, Hermanns-Le T, Paquet P, Pierard-Franchimont C. Skin viscoelasticity during hormone replacement therapy for climacteric ageing. Int J Cosmet Sci 2013; doi:10.1111/ics.12100. [Epub ahead of print].
75. Schliemann S, Antonov D, Manegold N, Elsner P. The lactic acid stinging test predicts susceptibility to cumulative irritation caused by two lipophilic irritants. Contact Dermatitis 2010; 63: 347–356.
76. Arjinpathana N, Asawanonda P. Glutathione as an oral whitening agent: a randomized, double-blind, placebo-controlled study. J Dermatolog Treat 2012; 23: 97–102.
77. Bodekaer M, Philipsen PA, Karlsmark T, Wulf HC. Good agreement between minimal erythema dose test reactions and objective measurements: an in vivo study of human skin. Photodermatol Photoimmunol Photomed 2013; 29: 190–195.
78. Kanechorn Na Ayuthaya P, Niumphradit N, Manosroi A, Nakakes A. Topical 5% tranexamic acid for the treatment of melasma in Asians: a double-blind randomized controlled clinical trial. J Cosmet Laser Ther 2012;14:150–154.
79. Angelova-Fischer I, Rippke F, Fischer TW, Neufang G, Zillikens D. A double-blind, randomized, vehicle-controlled efficacy assessment study of a skin care formulation for improvement of mild to moderately severe acne. J Eur Acad Dermatol Venereol 2013; 27(Suppl 2): 6–11.
80. Pierard GE, Pierard-Franchimont C, Scheen A. Critical assessment of diabetic xerosis. Expert Opin Med Diagn 2013; 7: 201–207.
81. Simpson E, Bohling A, Bielfeldt S, Bosc C, Kerrouche N. Improvement of skin barrier function in atopic dermatitis patients with a new moisturizer containing a ceramide precursor. J Dermatolog Treat 2013; 24: 122–125.
82. Bottcher B, Stahlhofer KJ, Mattle V, Seeber B, Brezinka C, Wildt L. Ultrasonographic assessment of skin thickness in patients with PCOS - a case-control study. Gynecol Endocrinol 2013; 29: 380–383.
83. Guerin-Moreau M, Leftheriotis G, Lecorre Y, Etienne M, Amode R, Hamel JF et al. High-frequency (20–50 MHz) ultrasonography of pseudoxanthoma elasticum skin lesions. Br J Dermatol 2013; 169: 1233–1239.
84. Turpeinen M, Raitio H, Pelkonen AS et al. Skin thickness in children treated with daily or periodical inhaled budesonide for mild persistent asthma. The Helsinki early intervention childhood asthma study. Pediatr Res 2010; 67: 221–225.
85. Lee MR, Nam GW, Jung YC et al. Comparison of the skin biophysical parameters of Southeast Asia females: forehead-cheek and ethnic groups. J Eur Acad Dermatol Venereol 2013; 27: 1521–1526.
86. Nguyen NT, Roberge D, Freeman CR, Wong C, Hines J, Turcotte RE. Skin elasticity as a measure of radiation fibrosis: is it reproducible and does it correlate with patient and physician-reported measures? Technol Cancer Res Treat 2013; [Epub ahead of print].
87. Yoon HS, Lee SR, Chung JH. Long-term topical oestrogen treatment of sun-exposed facial skin in post-menopausal women does not improve facial wrinkles or skin elasticity, but induces matrix metalloproteinase-1 expression. Acta Derm Venereol 2014; 94: 4–8.
88. Heimhalt-El Hamriti M, Schreiver C, Noerenberg A et al. Impaired skin microcirculation in paediatric patients with type 1 diabetes mellitus. Cardiovasc Diabetol 2013;12:115.
89. Petersen LJ. Direct comparison of laser Doppler flowmetry and laser Doppler imaging for assessment of experimentally-induced inflammation in human skin. Inflamm Res 2013; 62: 1073–1078.
90. Balu M, Mazhar A, Hayakawa CK et al. In vivo multiphoton NADH fluorescence reveals depth-dependent keratinocyte metabolism in human skin. Biophys J 2013; 104: 258–267.
91. Marco M, Giovanna M, Silvana C et al. Does skin hydration influence keratinocyte biology? In vivo evaluation of microscopic skin changes induced by moisturizers by means of reflectance confocal microscopy. Skin Res Technol 2013; 19: 299–307.
92. Miyamoto K, Kudoh H. Quantification and visualization of cellular NAD(P)H in young and aged female facial skin with in vivo two-photon tomography. Br J Dermatol 2013; 169(Suppl 2): 25–31.
93. Aschoff R, Schmitt J, Knuschke P, Koch E, Brautigam M, Meurer M. Evaluation of the atrophogenic potential of hydrocortisone 1% cream and pimecrolimus 1% cream in uninvolved forehead skin of patients with atopic dermatitis using optical coherence tomography. Exp Dermatol 2011; 20: 832–836.
94. Koller S, Inzinger M, Rothmund M et al. UV-induced alterations of the skin evaluated over time by reflectance confocal microscopy. J Eur Acad Dermatol Venereol 2013; doi:10.1111/jdv.12284. [Epub ahead of print].
95. Wurm EM, Longo C, Curchin C, Soyer HP, Prow TW, Pellacani G. In vivo assessment of chronological ageing and photoageing in forearm skin using reflectance confocal microscopy. Br J Dermatol 2012; 167: 270–279.
96. Anderson MS, Johnson J. Restoration of body image and self-esteem for women after cancer treatment: a rehabilitative strategy. Cancer Pract 1994; 2: 345–349.
97. Boehncke WH, Ochsendorf F, Paeslack I, Kaufmann R, Zollner TM. Decorative cosmetics improve the quality of life in patients with disfiguring skin diseases. Eur J Dermatol 2002; 12: 577–580.
98. Chan MF, Thng TG, Aw CW, Goh BK, Lee SM, Chua TL. Investigating factors associated with quality of life of vitiligo patients in Singapore. Int J Nurs Pract 2013; 19(Suppl 3): 3–10.
99. Dreyfus I, Bourrat E, Maruani A et al. Factors associated with impaired quality of life in adult patients suffering from Ichthyosis. Acta Derm Venereol 2013; doi:10.2340/00015555-1710. [Epub ahead of print].
100. Possel P, Ahrens S, Hautzinger M. Influence of cosmetics on emotional, autonomous, endocrinological, and immune reactions. Int J Cosmet Sci 2005; 27: 343–349.
101. Taggart LR, Ozolins L, Hardie H, Nyhof-Young J. Look good feel better workshops: a “big lift” for women with cancer. J Cancer Educ 2009; 24: 94–99.
102. Verma SM, Okawa J, Propert KJ, Werth VP. The impact of skin damage due to cutaneous lupus on quality of life. Br J Dermatol 2014; 170: 315–321.